Latest
Granit raises €5M to take billing work off French cliniciansMindmax raises $3.3M pre-seed for a spoken AI tutorFluoRok raises $30M Series A for HF-free fluorochemicalsKabilio raises €10M to put an AI agent inside Spanish accounting firmsAll funding coverage →Browse the database
Latest
Pick the LP first, then the 2027 conferenceBessemer Venture Partners closes $5.75B, mostly for growthQuantumLight Closes $500M Fund II – and Algorithmic VC Stops Being an ExperimentThe EIF’s €15B ETCI 2 Is Europe’s Biggest Bet Yet on Fixing the Scaleup GapAll investors coverage →By ticket size
By country
Corporate venture fund of MSD (Merck & Co.) investing in digital health and health technology companies globally, typically at growth and expansion stages.
MSD Global Health Innovation Fund invests at Series A. Sesamers tracks 1 portfolio company across 1 round. Its most recent tracked deal: Biolevate, Sep 2026.
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| Biolevate Paris, France Read the announcement → | Series A | Participant | Sep 2026 | €30M |